Bacterial 16S ribosomal RNA aminoacyl-tRNA site (16S rRNA A-site)

The bacterial 16S ribosomal RNA (rRNA) aminoacyl-tRNA site, commonly known as the A-site, is a fundamental component of the 30S small ribosomal subunit responsible for the decoding of genetic information during translation [1]. It functions as the primary checkpoint where the ribosome ensures the fidelity of protein synthesis by monitoring the base-pairing between the mRNA codon and the tRNA anticodon [2]. During translation, the A-site undergoes specific conformational changes, particularly involving the flipping out of highly conserved adenine residues (A1492 and A1493), to signal the acceptance of a correct tRNA [3]. This site is a primary target for several major classes of antibiotics, most notably aminoglycosides and tetracyclines [5]. Aminoglycosides bind to the A-site and stabilize the 'flipped-out' state regardless of codon-anticodon matching, leading to the production of mistranslated, non-functional proteins that ultimately cause bacterial cell death [4]. Because of the structural similarity between bacterial 16S rRNA and human mitochondrial 12S rRNA, drugs targeting this site can sometimes cause off-target toxicities such as permanent hearing loss and kidney damage [4][5].

Other names

16S rRNA decoding site30S ribosomal subunit A-siteAminoacyl-tRNA binding siteRibosomal decoding centerHelix 44 of 16S rRNA

Aminoglycosides bind to the internal loop of helix 44 in the 16S rRNA A-site, stabilizing the 'flipped-out' conformation of residues A1492 and A1493, which causes mRNA misreading and the production of toxic aberrant proteins [1][3]. Tetracyclines bind to the A-site to physically block the docking of aminoacyl-tRNA, thereby inhibiting the elongation phase of protein synthesis [2][5].